Sectm1b Inhibitors
Chemical inhibitors of Sectm1b can modulate its function by interacting with various cellular pathways that are essential for the protein's activity. Phloretin, by inhibiting glucose transporters GLUT1 and GLUT2, can impair the energy-dependent cellular functions where Sectm1b is involved, as immune cell interactions require energy which is found in glucose. Chelerythrine, through its inhibitory action on Protein Kinase C (PKC), can disrupt intracellular signaling pathways necessary for the functional activity of Sectm1b. Similarly, LY294002, by targeting the PI3K/Akt pathway, can decrease the functional activity of Sectm1b, a key element in immune modulation. PD98059 and U0126, both inhibitors of the MEK pathway, can prevent the activation of MAPK/ERK, leading to a reduction in Sectm1b's activity due to disruption of the signaling process. SB203580 specifically inhibits p38 MAPK, which can result in the inhibition of inflammatory response pathways in which Sectm1b is involved, while SP600125's inhibition of JNK can impair stress and inflammatory response signaling pathways reliant on Sectm1b.
Further modulation of Sectm1b activity is achieved through the use of BAPTA-AM, an intracellular calcium chelator, which by sequestering calcium ions can inhibit the signaling events involving Sectm1b. W-7 Hydrochloride, as a calmodulin antagonist, can disrupt calcium-dependent signaling processes essential for the function of Sectm1b. The inhibition of Src family tyrosine kinases by PP2 can also disrupt Sectm1b's activity, given the involvement of tyrosine kinases in immune function signaling pathways. Rapamycin's inhibition of mTOR, a regulator of cell growth and proliferation, can impair cellular processes necessary for the activity of Sectm1b. Lastly, Cyclosporin A's inhibition of calcineurin leads to a reduction in T-cell responses, and as Sectm1b plays a role in the immune system, this inhibition can lead to decreased function of Sectm1b.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits the glucose transporters GLUT1 and GLUT2. Sectm1b is known to be involved in immune cell interactions, which are energy-dependent. Inhibiting glucose uptake can impair the cellular functions where Sectm1b is involved. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a potent inhibitor of Protein Kinase C (PKC). Since PKC is involved in intracellular signaling pathways that Sectm1b may be a part of, inhibition of PKC can inhibit the signaling cascades necessary for Sectm1b's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of the PI3K/Akt pathway, which is central to many aspects of cell signaling and survival. As Sectm1b is involved in immune modulation, inhibiting PI3K/Akt pathway can decrease the functional activity of Sectm1b. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which prevents the activation of MAPK/ERK pathway. As Sectm1b is involved in immune cell signaling, inhibiting this pathway can lead to inhibition of the functional activity of Sectm1b. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. Since Sectm1b is implicated in immune responses, inhibition of p38 MAPK can inhibit the inflammatory response pathways in which Sectm1b is involved. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is involved in stress and inflammatory responses. By inhibiting JNK, the chemical can impair the signaling pathways that rely on this kinase, potentially leading to the inhibition of Sectm1b functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which blocks the activation of ERK1/2. Since Sectm1b is part of immune signaling pathways, inhibiting MEK1/2 can lead to a reduction in Sectm1b's activity due to disruption of the signaling process. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is an intracellular calcium chelator. Sectm1b is a part of cellular signaling pathways, where calcium signaling plays a crucial role. Chelating calcium can inhibit the signaling events in which Sectm1b is involved. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 Hydrochloride is a calmodulin antagonist. Calmodulin is involved in calcium signaling pathways. Inhibition of calmodulin can disrupt calcium-dependent signaling processes essential for Sectm1b's function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Since tyrosine kinases are involved in a variety of cell signaling pathways, including those related to immune function where Sectm1b operates, inhibition can disrupt Sectm1b's activity. | ||||||